Keywords: baxter, 2nd-qtr, sales, below, forecasts, international, says
Baxter's 2nd-qtr sales below forecasts
Article | 29 July 2002
Baxter International says that turnover in the second quarter of 2002advanced 8% to $2.02 billion. Net earnings for the reporting period fell 21% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
